A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
| Status: | Archived |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | April 2010 |
| End Date: | April 2011 |
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis in Transition From Interferon to Glatiramer Acetate (Copaxone®)
This study is expected to contribute to the body of knowledge on the benefits of individuals
with MS taking glatiramer acetate (Copaxone®). If patients have less spasticity when taking
glatiramer acetate (Copaxone®), they may be more likely to have an improved quality of life.
The hypotheses for this study are:
1. Study participants who transition from interferon therapy to glatiramer acetate
(Copaxone®) for a six month period will have a decrease in spasticity.
2. Study participants who transition from interferon therapy to glatiramer acetate
(Copaxone®) for a six month period will have a change in perceptions of the impact of
spasticity on their lives.
The purpose of this study is to determine if there is a change in spasticity and perceptions
of the impact of spasticity in individuals with multiple sclerosis who transition from
interferon to glatiramer acetate (Copaxone®).•
- Potential participants meeting the criteria will be identified by Shared Solutions and
informed of the study. Interested individuals will contact the investigator either by
email or telephone. Enrollment will continue until there are 110 participants starting
glatiramer acetate (Copaxone®).
- Potential participants will be informed of the details of the study, eligibility will
be confirmed, and participant's questions answered.
- The two study instruments and the sociodemographic questionnaire will be emailed or
mailed via UPS along with an information letter. May be returned either via email, fax
or UPS mail.
- At month 6 for each participant, the study instruments and sociodemographic
questionnaire will be sent a second time and returned to the investigator.
We found this trial at
1
site
Click here to add this to my saved trials
